medical devices

First Opinion By Margaret Goldberg

Patient advocacy groups and innovators must partner to advance new treatments

Health Tech By Katie Palmer

Experts debate the value of digital coaching for type 2 diabetes

First Opinion By Hilary Gentile and Sarah Cockle-Hearne

Health depends on the strength of the doctor/technology relationship

Health Tech By Elizabeth Cooney

Measuring blood sugar in real time is a game changer for patients — and a health tech success story

First Opinion By Jennifer Bright and Richard H. Chapman

It’s time to get health care value assessment right

Business By Alicia Diaz

Medical device firms’ payments to doctors far outstripped those from pharma, study shows

Opinions+ By Darius Lakdawalla, Peter Neumann and Gail Wilensky

Create a U.S. Institute of Health Technology Assessment to preserve innovation and control costs

First Opinion By Kurt Newman

It’s time to fast track innovation in medical devices for children

First Opinion By Eric D. Perakslis

A digital option is the right investment for at-home Covid-19 testing

First Opinion By Andrey Ostrovsky

Medicare should break an old rule to let breakthrough digital therapeutics save lives

First Opinion By Joy Sturm

Navigating the new ‘buy American’ drug landscape: opportunities for some, pitfalls for others

Health By Ron Winslow

How a Zoom forum is changing the way ICU doctors treat desperately ill Covid-19 patients

Health Tech By Erin Brodwin

Webinar: Inside the virtual care boom: What happens when the point of care becomes anywhere?

Biotech By Jonathan Saltzman — Boston Globe

Medical device startup raises almost $44M to advance a less-invasive treatment for fluid in the brain

In the Lab By Shraddha Chakradhar

Surgery and AI give amputees more precise control of a prosthetic hand, study shows

Opinions+ By Jonathan P. Gertler

Why medtech is a different beast than biotech in the life sciences pack

Exclusive By Erin Brodwin

Verily tangos at JPM with a health tech partner — and steps on a few toes

Health By Gideon Gil

Surgeons test-drive the amputation of the future with a mail-order limb, rerouted nerve, and prosthetic hand that grips like the real thing

First Opinion By Alexander Egilman, Joseph S. Ross and Amy Kapczynski

Confidentiality orders in drug, device lawsuits harm patients and the public

Opinions+ By Christopher Leo, Christian Thienel and Brendan Wang

Early price setting, other market access planning is key for early-stage drug, device companies

Health By Megan Thielking

Health tech companies often flop. But this researcher’s track record suggests there’s a strategy for success

First Opinion By Harold DeMonaco and Eric von Hippel

Patient-innovators fill gaps that industry hasn’t addressed — or can’t

First Opinion By Brian Block and Neeta Thakur

Cost-cutting jeopardizes many Americans’ access to lifesaving oxygen therapy

Health By Associated Press

FDA halts sales of pelvic mesh tied to injuries in women

In the Lab By Elizabeth Cooney

Michigan tops STAT Madness voting with a potential treatment for tinnitus